In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes

Journal of Proteomics

Volumn 136, Issue , 2016, Pages 234-247

  Wiśniewski, Jacek R ^a   Vildhede, Anna ^b   Norén, Agneta ^b   Artursson, Per ^b,c  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UPPSALA UNIVERSITY   (Sweden)

^c SCIENCE FOR LIFE LABORATORY   (Sweden)

Author keywords

'Proteomic Ruler'; 'Total Protein Approach'; ADME proteins; FASP; Human hepatocyte; Human hepatocyte proteome; Metabolism; Quantitative proteomics; Transporter

Indexed keywords

PROTEOME; XENOBIOTIC AGENT; TUMOR PROTEIN;

ARTICLE; CATABOLISM; CELL METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; FUNCTIONAL PROTEOMICS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER CELL; MEASUREMENT ACCURACY; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY; HEP-G2 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY;

CARCINOMA, HEPATOCELLULAR; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS;

EID: 84959362575     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2016.01.016     Document Type: Article

References (47)

1. Lodish H., Berk A., Zipursky S., Matsudaira P., Baltimore D., Darnell J. Molecular Cell Biology 2000, W.H. Freeman, New York. fourth ed.
2. Weibel E.R., Staubli W., Gnagi H.R., Hess F.A. Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J. Cell Biol. 1969, 42:68-91.
3. Berry M.N., AM Edwards The Hepatocyte Review 2000, Kulwer Academic Publishers.
4. Godoy P., Hewitt N.J., Albrecht U., Andersen M.E., Ansari N., Bhattacharya S., et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 2013, 87:1315-1530.
5. Ramboer E., Vanhaecke T., Rogiers V., Vinken M. Immortalized human hepatic cell lines for in vitro testing and research purposes. Methods Mol. Biol. 2015, 1250:53-76.
6. Berger E., Vega N., Weiss-Gayet M., Geloen A. Gene network analysis of glucose linked signaling pathways and their role in human hepatocellular carcinoma cell growth and survival in HuH7 and HepG2 cell lines. Biomed. Res. Int. 2015, 2015:821761.
7. Wisniewski J.R., Dus K., Mann M. Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins. Proteomics Clin. Appl. 2013, 7:225-233.
8. Wisniewski J.R., Ostasiewicz P., Mann M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J. Proteome Res. 2011, 10:3040-3049.
9. Wisniewski J.R., Ostasiewicz P., Dus K., Zielinska D.F., Gnad F., Mann M. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 2012, 8:611.
10. Wisniewski J.R., Hein M.Y., Cox J., Mann M. A "proteomic ruler" for protein copy number and concentration estimation without spike-in standards. Mol. Cell. Proteomics 2014, 13:3497-3506.
11. Vildhede A., Karlgren M., Svedberg E.K., Wisniewski J.R., Lai Y., Noren A., et al. Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactions. Drug Metab. Dispos. 2014, 42:1210-1218.
12. Karlgren M., Vildhede A., Norinder U., Wisniewski J.R., Kimoto E., Lai Y., et al. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. J. Med. Chem. 2012, 55:4740-4763.
13. Vildhede A., Wisniewski J.R., Noren A., Karlgren M., Artursson P. Comparative proteomic analysis of human liver tissue and isolated hepatocytes with a focus on proteins determining drug exposure. J. Proteome Res. 2015, 14:3305-3314.
14. Wisniewski J.R., Friedrich A., Keller T., Mann M., Koepsell H. The impact of high fat diet on metabolism and immune defense in small intestine mucosa. J. Proteome Res. 2014.
15. Wisniewski J.R., Koepsell H., Gizak A., D.Rakus Absolute protein quantification allows differentiation of cell specific metabolic routes and functions. Proteomics 2014.
16. Rakus D., Gizak A., Deshmukh A., JR Wisniewski Absolute quantitative profiling of the key metabolic pathways in slow and fast skeletal muscle. J. Proteome Res. 2015.
17. Lecluyse E.L., Alexandre E. Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol. Biol. 2010, 640:57-82.
18. Nielsen P.A., Olsen J.V., Podtelejnikov A.V., Andersen J.R., Mann M., Wisniewski J.R. Proteomic mapping of brain plasma membrane proteins. Mol. Cell. Proteomics 2005, 4:402-408.
19. Wisniewski J.R., Mann M. Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis. Anal. Chem. 2012, 84:2631-2637.
20. Wisniewski J.R., Gaugaz F.Z. Fast and sensitive total protein and peptide assays for proteomic analysis. Anal. Chem. 2015, 87:4110-4116.
21. Wisniewski J.R., Zougman A., Mann M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J. Proteome Res. 2009, 8:5674-5678.
22. Wisniewski J.R., Prus G. Homogenous phase enrichment of cysteine-containing peptides for improved proteome coverage. Anal. Chem. 2015, 87:6861-6867.
23. Wisniewski J.R., Rakus D. Multi-enzyme digestion FASP and the 'Total Protein Approach'-based absolute quantification of the Escherichia coli proteome. J. Proteome 2014, 109:322-331.
24. Dimayacyac-Esleta B.R., Tsai C.F., Kitata R.B., PY Lin, WK Choong, TD Lin, et al. Rapid high-pH reverse phase StageTip for sensitive small-scale membrane proteomic profiling. Anal. Chem. 2015.
25. Matsson P., Fenu L.A., Lundquist P., Wisniewski J.R., Kansy M., Artursson P. Quantifying the impact of transporters on cellular drug permeability. Trends Pharmacol. Sci. 2015, 36:255-262.
26. Rakus D., Gizak A., Deshmukh A., Wisniewski J.R. Absolute quantitative profiling of the key metabolic pathways in slow and fast skeletal muscle. J. Proteome Res. 2015, 14:1400-1411.
27. Wisniewski J.R., Dus-Szachniewicz K., Ostasiewicz P., Ziolkowski P., Rakus D., Mann M. Absolute proteome analysis of colorectal mucosa, adenoma, and cancer reveals drastic changes in fatty acid metabolism and plasma membrane transporters. J. Proteome Res. 2015, 14:4005-4018.
28. Schmucker D.L. Aging and the liver: an update. J. Gerontol. A Biol. Sci. Med. Sci. 1998, 53:B315-B320.
29. Toyoda H., Bregerie O., Vallet A., Nalpas B., Pivert G., Brechot C., et al. Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis. Gut 2005, 54:297-302.
30. Watanabe T., Tanaka Y. Age-related alterations in the size of human hepatocytes. A study of mononuclear and binucleate cells. Virchows Arch. B. 1982, 39:9-20.
31. Brown G.C. Total cell protein concentration as an evolutionary constraint on the metabolic control distribution in cells. J. Theor. Biol. 1991, 153:195-203.
32. Brockhausen I., Schachter H., Stanley P. O-GalNAc Glycans. Essentials of Glycobiology 2009, Cold Spring Harbor, NY. second ed. A. Varki, C. RD, E. JD, F. HH, P. Stanley, B. CR (Eds.).
33. Stanley P., Schachter H., Taniguchi N. N-Glycans. Essentials of Glycobiology 2009, Cold Spring Harbor, NY. second ed. A. Varki, C. RD, E. JD, F. HH, P. Stanley, B. CR (Eds.).
34. Varki A., Schauer R. Sialic Acids. Essentials of Glycobiology 2009, Cold Spring Harbor, NY. second ed. A. Varki, C. RD, E. JD, F. HH, P. Stanley, B. CR, E. al. (Eds.).
35. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
36. International Transporter C, Giacomini K.M., Huang S.M., Tweedie D.J., Benet L.Z., Brouwer K.L., et al. Membrane transporters in drug development. Nat. Rev. Drug Discov. 2010, 9:215-236.
37. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular Biology of the Cell 1994, Garland Publishing Inc., New York.
38. Robin E.D., Wong R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J. Cell. Physiol. 1988, 136:507-513.
39. De Pinto V., Messina A., Lane D.J., Lawen A. Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS Lett. 2010, 584:1793-1799.
40. Achour B., Barber J., Rostami-Hodjegan A. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis. Drug Metab. Dispos. 2014, 42:1349-1356.
41. Guillouzo A., Corlu A., Aninat C., Glaise D., Morel F., Guguen-Guillouzo C. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 2007, 168:66-73.
42. Le Vee M., Jigorel E., Glaise D., Gripon P., Guguen-Guillouzo C., Fardel O. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur. J. Pharm. Sci. 2006, 28:109-117.
43. Lee T.K., Hammond C.L., Ballatori N. Intracellular glutathione regulates taurocholate transport in HepG2 cells. Toxicol. Appl. Pharmacol. 2001, 174:207-215.
44. Westerink W.M., Schoonen W.G. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. in Vitro 2007, 21:1581-1591.
45. Wilkening S., Stahl F., Bader A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab. Dispos. 2003, 31:1035-1042.
46. Rowe C., Gerrard D.T., Jenkins R., Berry A., Durkin K., Sundstrom L., et al. Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation. Hepatology 2013, 58:799-809.
47. Vizcaino J.A., Deutsch E.W., Wang R., Csordas A., Reisinger F., Rios D., et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 2014, 32:223-226.